Ebola Outbreak Surpasses 3,000 Cases as First Human Vaccine Trial for Rare Bundibugyo Virus Begins
discovermagazine - Learn how a rare Ebola strain has fueled one of the largest outbreaks on record and what the first human vaccine trial could mean for containing the outbreak.
AI Summary: An Ebola outbreak in eastern DR Congo has surpassed 3,000 reported cases and is poised to become the second-largest on record. Authorities have launched the first human vaccine trial targeting the Bundibugyo strain while laboratory tests show stockpiled Ebola vaccines generate antibodies against Bundibugyo, intensifying both response operations and urgent vaccine research.
Related Stories
Dual Lassa–rabies vaccine phase 1 shows safety in humans / 6 wks
Moderna launches mRNA bird‑flu vaccine trial as preparedness ramps up / 3 months
Pfizer's Lyme vaccine heads to FDA after mixed trial results / 4 months
Experimental plague vaccine protects immune‑deficient mice from pneumonic plague / 2 days
UK begins human testing of first AI-designed 'universal' vaccine / 7 wks
Favipiravir shows promise in Lassa fever Phase 2 trial / 2 months
Engineered 15‑strain biotherapeutic matches donor FMT for C. difficile / 7 wks
StackHealth RSS
You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try Medicare Advantage (not listed), Diagnostics, Zoonotic Disease, Digital Health and look for the RSS link.
StackHealth Time Machine